title: Optimising haemopoietic cell transplantation.
authors.forename: Priya
authors.initials: P
authors.lastname: Venkatesan
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D018450:Disease Progression; D018572:Disease-Free Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D019653:Myeloablative Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D009190:Myelodysplastic Syndromes / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D013997:Time Factors; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D016896:Treatment Outcome
chemical_list: D019653:Myeloablative Agonists